Comparison of Preoperative Inflammation-based Prognostic Scores in Patients with Colorectal Cancer

Yoshiyuki Suzuki, Koji Okabayashi, Hirotoshi Hasegawa, Masashi Tsuruta, Kohei Shigeta, Takayuki Kondo, Yuukou Kitagawa

研究成果: Article

23 引用 (Scopus)

抄録

Objective: To evaluate the prognostic impact of the systemic inflammation score (SIS) in colorectal cancer (CRC) patients in comparison with a conventional inflammation-based score, the modified Glasgow Prognostic Score (mGPS). Summary Background Data: The SIS, which is calculated based on the preoperative serum albumin level and lymphocyte-to-monocyte ratio, is a reported prognostic marker in clear-cell renal cell carcinoma. However, the utility of the SIS in CRC remains unclear. Methods: The study involved 727 CRC patients who underwent curative resection between September 2005 and December 2011. The prognostic impact of SIS and mGPS was evaluated using survival analyses. The prognostic impact of each score was compared visually by means of time-dependent receiver operating characteristics analysis. Results: The median age of the patients was 67 (interquartile range: 58-75) years. The TNM stage distribution was stage I, 29.8%; stage II, 33.6%; stage III, 30.3%; and stage IV, 6.3%. The median follow-up period was 5.61 years (interquartile range: 4.24-7.06). Multivariate analysis revealed that an increased SIS and mGPS were independent prognostic factors (SIS: P = 0.018; mGPS: P = 0.005, respectively). The time-dependent receiver operating characteristics curve of the SIS was superior to that of the mGPS throughout the observation period. The estimated area under the curve (AUC) of the SIS was significantly higher than that of the mGPS (7-yr survival: SIS 0.673, mGPS 0.605, P = 0.030). Conclusions: The SIS is a novel prognostic factor in CRC patients. Additionally, the SIS is an alternative inflammation-based biomarker, which may improve the prediction of clinical outcomes.

元の言語English
ページ(範囲)527-531
ページ数5
ジャーナルAnnals of Surgery
267
発行部数3
DOI
出版物ステータスPublished - 2018 3 1

Fingerprint

Colorectal Neoplasms
Inflammation
ROC Curve
Survival Analysis
Renal Cell Carcinoma
Serum Albumin
Area Under Curve
Monocytes
Multivariate Analysis
Biomarkers
Observation
Lymphocytes
Survival

ASJC Scopus subject areas

  • Surgery

これを引用

Comparison of Preoperative Inflammation-based Prognostic Scores in Patients with Colorectal Cancer. / Suzuki, Yoshiyuki; Okabayashi, Koji; Hasegawa, Hirotoshi; Tsuruta, Masashi; Shigeta, Kohei; Kondo, Takayuki; Kitagawa, Yuukou.

:: Annals of Surgery, 巻 267, 番号 3, 01.03.2018, p. 527-531.

研究成果: Article

@article{546d051e809542e4b68f19aa3cab80be,
title = "Comparison of Preoperative Inflammation-based Prognostic Scores in Patients with Colorectal Cancer",
abstract = "Objective: To evaluate the prognostic impact of the systemic inflammation score (SIS) in colorectal cancer (CRC) patients in comparison with a conventional inflammation-based score, the modified Glasgow Prognostic Score (mGPS). Summary Background Data: The SIS, which is calculated based on the preoperative serum albumin level and lymphocyte-to-monocyte ratio, is a reported prognostic marker in clear-cell renal cell carcinoma. However, the utility of the SIS in CRC remains unclear. Methods: The study involved 727 CRC patients who underwent curative resection between September 2005 and December 2011. The prognostic impact of SIS and mGPS was evaluated using survival analyses. The prognostic impact of each score was compared visually by means of time-dependent receiver operating characteristics analysis. Results: The median age of the patients was 67 (interquartile range: 58-75) years. The TNM stage distribution was stage I, 29.8{\%}; stage II, 33.6{\%}; stage III, 30.3{\%}; and stage IV, 6.3{\%}. The median follow-up period was 5.61 years (interquartile range: 4.24-7.06). Multivariate analysis revealed that an increased SIS and mGPS were independent prognostic factors (SIS: P = 0.018; mGPS: P = 0.005, respectively). The time-dependent receiver operating characteristics curve of the SIS was superior to that of the mGPS throughout the observation period. The estimated area under the curve (AUC) of the SIS was significantly higher than that of the mGPS (7-yr survival: SIS 0.673, mGPS 0.605, P = 0.030). Conclusions: The SIS is a novel prognostic factor in CRC patients. Additionally, the SIS is an alternative inflammation-based biomarker, which may improve the prediction of clinical outcomes.",
keywords = "biomarker, colorectal cancer, inflammation, prognosis, time-dependent ROC curve",
author = "Yoshiyuki Suzuki and Koji Okabayashi and Hirotoshi Hasegawa and Masashi Tsuruta and Kohei Shigeta and Takayuki Kondo and Yuukou Kitagawa",
year = "2018",
month = "3",
day = "1",
doi = "10.1097/SLA.0000000000002115",
language = "English",
volume = "267",
pages = "527--531",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Comparison of Preoperative Inflammation-based Prognostic Scores in Patients with Colorectal Cancer

AU - Suzuki, Yoshiyuki

AU - Okabayashi, Koji

AU - Hasegawa, Hirotoshi

AU - Tsuruta, Masashi

AU - Shigeta, Kohei

AU - Kondo, Takayuki

AU - Kitagawa, Yuukou

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Objective: To evaluate the prognostic impact of the systemic inflammation score (SIS) in colorectal cancer (CRC) patients in comparison with a conventional inflammation-based score, the modified Glasgow Prognostic Score (mGPS). Summary Background Data: The SIS, which is calculated based on the preoperative serum albumin level and lymphocyte-to-monocyte ratio, is a reported prognostic marker in clear-cell renal cell carcinoma. However, the utility of the SIS in CRC remains unclear. Methods: The study involved 727 CRC patients who underwent curative resection between September 2005 and December 2011. The prognostic impact of SIS and mGPS was evaluated using survival analyses. The prognostic impact of each score was compared visually by means of time-dependent receiver operating characteristics analysis. Results: The median age of the patients was 67 (interquartile range: 58-75) years. The TNM stage distribution was stage I, 29.8%; stage II, 33.6%; stage III, 30.3%; and stage IV, 6.3%. The median follow-up period was 5.61 years (interquartile range: 4.24-7.06). Multivariate analysis revealed that an increased SIS and mGPS were independent prognostic factors (SIS: P = 0.018; mGPS: P = 0.005, respectively). The time-dependent receiver operating characteristics curve of the SIS was superior to that of the mGPS throughout the observation period. The estimated area under the curve (AUC) of the SIS was significantly higher than that of the mGPS (7-yr survival: SIS 0.673, mGPS 0.605, P = 0.030). Conclusions: The SIS is a novel prognostic factor in CRC patients. Additionally, the SIS is an alternative inflammation-based biomarker, which may improve the prediction of clinical outcomes.

AB - Objective: To evaluate the prognostic impact of the systemic inflammation score (SIS) in colorectal cancer (CRC) patients in comparison with a conventional inflammation-based score, the modified Glasgow Prognostic Score (mGPS). Summary Background Data: The SIS, which is calculated based on the preoperative serum albumin level and lymphocyte-to-monocyte ratio, is a reported prognostic marker in clear-cell renal cell carcinoma. However, the utility of the SIS in CRC remains unclear. Methods: The study involved 727 CRC patients who underwent curative resection between September 2005 and December 2011. The prognostic impact of SIS and mGPS was evaluated using survival analyses. The prognostic impact of each score was compared visually by means of time-dependent receiver operating characteristics analysis. Results: The median age of the patients was 67 (interquartile range: 58-75) years. The TNM stage distribution was stage I, 29.8%; stage II, 33.6%; stage III, 30.3%; and stage IV, 6.3%. The median follow-up period was 5.61 years (interquartile range: 4.24-7.06). Multivariate analysis revealed that an increased SIS and mGPS were independent prognostic factors (SIS: P = 0.018; mGPS: P = 0.005, respectively). The time-dependent receiver operating characteristics curve of the SIS was superior to that of the mGPS throughout the observation period. The estimated area under the curve (AUC) of the SIS was significantly higher than that of the mGPS (7-yr survival: SIS 0.673, mGPS 0.605, P = 0.030). Conclusions: The SIS is a novel prognostic factor in CRC patients. Additionally, the SIS is an alternative inflammation-based biomarker, which may improve the prediction of clinical outcomes.

KW - biomarker

KW - colorectal cancer

KW - inflammation

KW - prognosis

KW - time-dependent ROC curve

UR - http://www.scopus.com/inward/record.url?scp=85042420478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042420478&partnerID=8YFLogxK

U2 - 10.1097/SLA.0000000000002115

DO - 10.1097/SLA.0000000000002115

M3 - Article

C2 - 27984214

AN - SCOPUS:85042420478

VL - 267

SP - 527

EP - 531

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 3

ER -